Molecular Imaging of Atheroma: Deciphering How and When to Use ¹⁸F-Sodium Fluoride and ¹⁸F-Fluorodeoxyglucose

Circ Cardiovasc Imaging. 2017 Mar;10(3):e006183. doi: 10.1161/CIRCIMAGING.117.006183.

Authors

Ahmed Tawakol¹, Michael T Osborne², Zahi A Fayad²

Affiliations

¹ From the Cardiology Division Department of Medicine, and Cardiac MR PET CT Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA (A.T., M.T.O); and Translational and Molecular Imaging Institute, Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (Z.A.F.). atawakol@mgh.harvard.edu.
² From the Cardiology Division Department of Medicine, and Cardiac MR PET CT Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA (A.T., M.T.O); and Translational and Molecular Imaging Institute, Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (Z.A.F.).

No abstract available

Keywords: Editorials; atherosclerosis; fluorodeoxyglucose; positron emission tomography / computed tomography; sodium fluoride; stroke.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Fluorine Radioisotopes
Fluorodeoxyglucose F18*
Humans
Molecular Imaging
Plaque, Atherosclerotic
Positron-Emission Tomography
Radiopharmaceuticals
Sodium Fluoride*
Tomography, X-Ray Computed

Substances

Fluorine Radioisotopes
Radiopharmaceuticals
Fluorodeoxyglucose F18
Sodium Fluoride

Grants and funding